Multani Pharmaceuticals Limited (Analytical Division) is a NABL-accredited and Government of India-approved Testing Laboratory for Drugs, AYUSH products, and Food products. It was established in 2008 and approved for the testing of Ayurvedic, Unani, and Siddha Drugs from 14-07-2010, vide Ayurvedic License No. UK.AY.DTL-02/2010, by the Directorate of Ayurvedic & Unani services, Dehradun, under the Department of AYUSH. The NABL certification is valid till 21st June 2023.
Subsequently, the Laboratory was approved for the testing of Drugs & Pharmaceuticals by the Drug Controller & Licensing Authority, Directorate of Health Services, Dehradun, vide Approval No. 1/UA/CTL/2013, on 01-11-2013. It has also been certified as a GLP Compliant Laboratory, under Schedule 1 of the Drugs and Cosmetics Act 1940.
We have successfully participated in the International Proficiency Testing Program and supported more than 200 esteemed Drug Manufacturing Companies and Government Institutions in the field of Quality Control and Basic Research. We are proud to house the best team of professionals who work with the utmost confidentiality and transparency.
The hallmark of a trustworthy brand is the level of quality exhibited by its products. Quality is essential to establishing a strong foothold in the market as well as ensuring sustainable growth in the long run. With this belief in mind, Multani has invested in the requisite infrastructure, technological processes, and professionals to guarantee quality control at every stage of production.
We communicate with all our stakeholders, such as consumers, healthcare representatives, patients, etc., to garner feedback and suggestions on ways to further improve the quality of our products. From recipe formulation to sourcing, processing, and transformation of raw material into consumable commodities, we make sure to consult and follow the latest scientific literature at all given times. Our manufacturing processes are in line with the regulatory requirements and our products undergo multiple checks prior to entering the marketplace.
Paying close attention to quality control has allowed use to reduce defects, improve resource utilisation, reduce costs, and strengthen our compliance burden. Thus, quality is and will always remain the focal point of our business strategy.